Dana-Farber Cancer Institute and Lifespan seek to partner in Rhode Island

摘要

PROVIDENCE – The Dana-Farber Cancer Institute (Dana-Farber) and Lifespan Health System have signed a letter of intent to enter into a partnership in Rhode Island. The goal of this inno- vative arrangement is to elevate the level of cancer treatment for patients seeking care at Lifespan-affiliated insti- tutions, and to benefit both organiza- tions' clinical, teaching and research missions. As envisioned, the partnership will provide a seamless system of care for patients needing treatment for rare and complex cancers. It will also facilitate access for Lifespan cancer patients to a broader array of clinical trials, and to emerging and novel cancer therapies.